Andrew R. Allen
2011
In 2011, Andrew R. Allen earned a total compensation of $682K as EVP of Clinical and Pre-Clinical Development and Chief Medical Officer at Clovis Oncology, a 75% increase compared to previous year.
Compensation breakdown
| Bonus | $150,000 |
|---|---|
| Option Awards | $149,661 |
| Salary | $366,667 |
| Other | $15,685 |
| Total | $682,012 |
Allen received $366.7K in salary, accounting for 54% of the total pay in 2011.
Allen also received $150K in bonus, $149.7K in option awards and $15.7K in other compensation.
Rankings
In 2011, Andrew R. Allen's compensation ranked 7,027th out of 10,747 executives tracked by ExecPay. In other words, Allen earned more than 34.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,027 out of 10,747 | 35th |
Division Manufacturing | 2,566 out of 3,960 | 35th |
Major group Chemicals And Allied Products | 618 out of 1,038 | 41st |
Industry group Drugs | 421 out of 786 | 46th |
Industry Pharmaceutical Preparations | 327 out of 571 | 43rd |
Source: SEC filing on April 29, 2013.
Allen's colleagues
We found four more compensation records of executives who worked with Andrew R. Allen at Clovis Oncology in 2011.